Latest Recruitment News

Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.

Lion Rock Minerals announces a leadership transition as CEO Casper Adson steps into a technical advisory role, with the Board seeking a new CEO to strengthen on-ground presence and accelerate exploration at the Minta Project in Cameroon.

Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.

Entropy Neurodynamics reports a 14.8% reduction in half-year losses while progressing a pioneering clinical trial for Binge Eating Disorder using its proprietary psychedelic drug TRP-8803. The company also secured $6.1 million in new funding and strategic collaborations to enhance its neuropsychiatry platform.

AF Legal Group Limited has reported a robust half-year performance, with revenue climbing 40% to $17.8 million and profits reaching new heights, driven by strategic acquisitions and operational efficiencies.

Paradigm Biopharmaceuticals reports a sharp rise in half-year losses as it intensifies investment in its pivotal Phase 3 trial for knee osteoarthritis, setting sights on a critical interim analysis in mid-2026. The company also expands its osteoarthritis pipeline and maintains strong funding amid a strengthening biotech sector.

Cleo Diagnostics reported a 53% drop in revenues and a slight increase in net loss to $1.98 million for H1 2025, while progressing its pivotal FDA clinical trial for an ovarian cancer blood test with strong regulatory and commercial milestones.

Vitura Health Limited reported an 8.3% rise in half-year revenues to $67.87 million, driven by medicinal cannabis sales and telehealth services, yet posted a consolidated loss of $986,341 due to margin pressures and increased costs. Leadership changes and strategic investments mark a pivotal phase for the digital health and medicinal cannabis player.

Hiremii Limited has reported a record half-year revenue of $16.1 million, boosted by its acquisition of Prince Migration and advances in its AI recruitment platform. Despite a modest loss, the company is positioning itself for growth through technology innovation and strategic capital raises.

NextEd Group Limited reported a 16.7% rise in underlying EBITDA and a 92% reduction in NPAT loss for H1 FY26, underpinned by AI integration and a strategic shift to higher-margin education segments.

The Agency Group Australia Ltd has reported a solid half-year performance with revenue rising 18% to $57.1 million and a 34% jump in gross commission income. The company narrowed its net loss and improved EBITDA, driven by strong sales and agent recruitment.

Tasmea Limited posted a robust 62.4% revenue increase to $400.5 million in H1 FY26, alongside a 32.2% rise in underlying profit after tax, despite a dip in statutory net profit. The acquisition of WorkPac Group marks a strategic expansion into workforce solutions.